OncoMed Pharmaceuticals Aktie
WKN DE: A1W2SS / ISIN: US68234X1028
08.05.2014 18:49:05
|
OncoMed Pharma Q1 Loss Widens
(RTTNews) - OncoMed Pharmaceuticals, Inc. (OMED) Thursday reported first-quarter loss of $13.9 million or $0.47 per share, compared to a loss of $8.6 million or $7.92 per share in the same period last year.
On average, four analysts polled by Thomson Reuters expected the company to earn $0.13 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues increased to $6.0 million from $2.9 million last year. Analysts expected revenues of $16.58 million.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu OncoMed Pharmaceuticals Incmehr Nachrichten
Keine Nachrichten verfügbar. |